before number of years, the united kingdom has witnessed a revolution in healthcare fat‑loss treatment plans — with the introduction of semaglutide (Wegovy®) on the increasing acceptance of tirzepatide (Mounjaro®). Now, An additional identify is drawing consideration in both of those medical and